BioCentury
ARTICLE | Politics & Policy

China finalizes list of foreign drugs eligible for Priority Review

November 2, 2018 5:32 PM UTC

China’s Drug Evaluation Center posted its final list of 40 drugs approved in the U.S., EU or Japan that are eligible for Priority Review in China.

On Aug. 8, the center announced the preliminary list with 48 drugs; public comments were due Aug. 18 (see "China Releases List of Overseas Drugs Eligible for Priority Review")...